EICHORCondition: B Lymphoblastic Leukemia · Sponsor: National University Hospital, Singapore
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The primary objective of this trial is to improve the overall survival rate of children and young adult with B-lineage acute lymphoblastic leukemia (B-ALL) in Singapore and Malaysia in the context of a multicenter cooperative trial using a risk-stratified therapy.
This description comes directly from the study's public registry record.
Allen Eng Juh Yeoh, MBBS · +65 67724406 · paeyej@nus.edu.sg
Always discuss trial participation with your own doctor first.
| Subang Jaya Medical Centre | Kuala Lumpur, Malaysia | Recruiting |
| University Malaya Medical Centre | Kuala Lumpur, Malaysia | Recruiting |
| KK Women's and Children's Hospital | Singapore, Singapore | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06336395